Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: METASTATIC, . Treffer: 659
2023
Ascierto, PA; Mandalà, M; Ferrucci, PF; Guidoboni, M; Rutkowski, P; Ferraresi, V; Arance, A; Guida, M; Maiello, E; Gogas, H; Richtig, E; Fierro, MT; Lebbè, C; Helgadottir, H; Queirolo, P; Spagnolo, F; Tucci, M; Del, Vecchio, M; Gonzales, Cao, M; Minisini, AM; De, Placido, S; Sanmamed, MF; Mallardo, D; Curvietto, M; Melero, I; Palmieri, G; Grimaldi, AM; Giannarelli, D; Dummer, R; Chiarion, Sileni, V
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial.
J Clin Oncol. 2023; 41(2): 212-221.
Doi: 10.1200/JCO.21.02961
Web of Science
PubMed
FullText
FullText_MUG
Bögemann, M; Facchini, G; Bauernhofer, T; Cathomas, R; Xylinas, E; Tombal, B
Role of apalutamide in the treatment landscape for patients with advanced prostate cancer: an expert opinion statement of European clinical practice.
Ir J Med Sci. 2023;
Doi: 10.1007/s11845-023-03303-y
Web of Science
PubMed
FullText
FullText_MUG
Eichholz, T; Döring, M; Giardino, S; Gruhn, B; Seitz, C; Flaadt, T; Schwinger, W; Ebinger, M; Holzer, U; Mezger, M; Teltschik, HM; Sparber-Sauer, M; Koscielniak, E; Abele, M; Handgretinger, R; Lang, P
Haploidentical hematopoietic stem cell transplantation as individual treatment option in pediatric patients with very high-risk sarcomas.
Front Oncol. 2023; 13:1064190
Doi: 10.3389/fonc.2023.1064190
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Karner, C; Anders, I; Vejzovic, D; Szkandera, J; Scheipl, S; Deutsch, AJA; Weiss, L; Vierlinger, K; Kolb, D; Kühberger, S; Heitzer, E; Habisch, H; Zhang, F; Madl, T; Reininger-Gutmann, B; Liegl-Atzwanger, B; Rinner, B
Targeting epigenetic features in clear cell sarcomas based on patient-derived cell lines.
J Transl Med. 2023; 21(1): 54
Doi: 10.1186/s12967-022-03843-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kashofer, K; Reich, O; Regauer, S
Acquisition of Genetic Aberrations During the Progression of High-Grade Intraepithelial Lesions/Micro-Invasive Squamous Cancers to Widely Invasive Cervical Squamous Cell Cancer.
Arch Pathol Lab Med. 2023;
Doi: 10.5858/arpa.2022-0310-OA
PubMed
FullText
FullText_MUG
Kendzia, S; Franke, S; Kröhler, T; Golob-Schwarzl, N; Schweiger, C; Toeglhofer, AM; Skofler, C; Uranitsch, S; El-Heliebi, A; Fuchs, J; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Yaspo, ML; Reinhard, C; Schäfer, R; Keilholz, U; Regenbrecht, C; Schicho, R; Fickert, P; Lax, SF; Erdmann, F; Schulz, MH; Kiemer, AK; Haybaeck, J; Kessler, SM
A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer.
Mol Cancer. 2023; 22(1):89
Doi: 10.1186/s12943-023-01787-x
PubMed
FullText
FullText_MUG
Kränke, T; Tripolt-Droschl, K; Röd, L; Hofmann-Wellenhof, R; Koppitz, M; Tripolt, M
New AI-algorithms on smartphones to detect skin cancer in a clinical setting-A validation study.
PLoS One. 2023; 18(2):e0280670
Doi: 10.1371/journal.pone.0280670
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
Leitner, L; Bratschitsch, G; Kostwein, A; Sadoghi, P; Smolle, M; Leithner, A; Posch, F
More help than harm: surgery for metastatic spinal cord compression is associated with more favorable overall survival within a propensity score analysis.
Eur Spine J. 2023;
Doi: 10.1007/s00586-023-07755-9
Web of Science
PubMed
FullText
FullText_MUG
Piccinelli, ML; Barletta, F; Tappero, S; Cano, Garcia, C; Incesu, RB; Morra, S; Scheipner, L; Tian, Z; Luzzago, S; Mistretta, FA; Ferro, M; Saad, F; Shariat, SF; Ahyai, S; Longo, N; Tilki, D; Chun, FKH; Terrone, C; Briganti, A; de, Cobelli, O; Musi, G; Karakiewicz, PI
Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality-free Survival in Surgically Treated Papillary Renal Cell Carcinoma Patients.
Eur Urol Focus. 2023;
Doi: 10.1016/j.euf.2023.03.014
PubMed
FullText
FullText_MUG
Suppan, C; Balic, M
Current standards and future outlooks in metastatic Her2-positive breast cancer
BREAST CARE. 2023;
Doi: 10.1159/000528756
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Tappero, S; Barletta, F; Piccinelli, ML; Cano, Garcia, C; Incesu, RB; Morra, S; Scheipner, L; Tian, Z; Parodi, S; Dell'Oglio, P; Briganti, A; de, Cobelli, O; Chun, FKH; Graefen, M; Mirone, V; Ahyai, S; Saad, F; Shariat, SF; Suardi, N; Borghesi, M; Terrone, C; Karakiewicz, PI
Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer.
Urol Oncol. 2023;
Doi: 10.1016/j.urolonc.2023.01.015
PubMed
FullText
FullText_MUG
Tappero, S; Barletta, F; Piccinelli, ML; Cano, Garcia, C; Incesu, RB; Morra, S; Scheipner, L; Tian, Z; Parodi, S; Dell'Oglio, P; Palumbo, C; Briganti, A; De, Cobelli, O; Chun, FKH; Graefen, M; Longo, N; Ahyai, S; Saad, F; Shariat, SF; Suardi, N; Borghesi, M; Terrone, C; Karakiewicz, PI
The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm.
Eur Urol Focus. 2023;
Doi: 10.1016/j.euf.2023.02.010
PubMed
FullText
FullText_MUG
2022
Boos, SL; Loevenich, LP; Vosberg, S; Engleitner, T; Öllinger, R; Kumbrink, J; Rokavec, M; Michl, M; Greif, PA; Jung, A; Hermeking, H; Neumann, J; Kirchner, T; Rad, R; Jung, P
Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer.
Cell Mol Gastroenterol Hepatol. 2022; 13(2): 517-540.
Doi: 10.1016/j.jcmgh.2021.10.008
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Dietzsch, S; Braesigk, A; Seidel, C; Remmele, J; Kitzing, R; Schlender, T; Mynarek, M; Geismar, D; Jablonska, K; Schwarz, R; Pazos, M; Weber, DC; Frick, S; Gurtner, K; Matuschek, C; Harrabi, SB; Glück, A; Lewitzki, V; Dieckmann, K; Benesch, M; Gerber, NU; Obrecht, D; Rutkowski, S; Timmermann, B; Kortmann, RD
Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial.
Strahlenther Onkol. 2022; 198(3):282-290
Doi: 10.1007/s00066-021-01822-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fluhrer, H; Hutterer, GC; Golbeck, S; Stidl, M; Niedrist, T; Pichler, R; Mischinger, J; Seles, M; Mannweiler, S; Spiegelberg, J; Bauernhofer, T; Jost, PJ; Ahyai, S; Zigeuner, R; Pichler, M; Barth, DA
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up.
Ther Adv Med Oncol. 2022; 14: 17588359221134065
Doi: 10.1177/17588359221134065
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
Gawish, A; Abdulayev, N; El-Arayed, S; Rollich, B; Ochel, HJ; Brunner, TB
Metabolic response after 68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases prostate cancer
CLIN TRANSL ONCOL. 2022;
Doi: 10.1007/s12094-022-03002-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gerger, A; Eisterer, W; Fuxius, S; Bastian, S; Koeberle, D; Welslau, M; Sanoyan, DA; Maas, C; Uhlig, J; Fenchel, K; Greil, R; VON, DER, Heyde, E; Agocs, GR; Weide, R; Schwager, M; Reichenbach, F; Modest, DP; Fritsch, R
Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma - MORSECRC.
Anticancer Res. 2022; 42(10):4773-4785
Doi: 10.21873/anticanres.15982
Web of Science
PubMed
FullText
FullText_MUG
Ghert, M; Schneider, P; Guyatt, G; Thabane, L; Vélez, R; O'Shea, T; Randall, RL; Turcotte, R; Wilson, D; Wunder, JS; Baptista, AM; Cheng, EY; Doung, YC; Ferguson, PC; Giglio, V; Hayden, J; Heels-Ansdell, D; Khan, SA; Sampath, Kumar, V; McKay, P; Miller, B; van, de, Sande, M; Zumárraga, JP; Bhandari, M, , Prophylactic, Antibiotic, Regimens, in, Tumor, Surgery, (PARITY), Investigators, , Prophylactic, Antibiotic, Regimens, in, Tumor, Surgery, (PARITY), Investigators
Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial.
JAMA Oncol. 2022; 8(3):345-353
Doi: 10.1001/jamaoncol.2021.6628
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jakubauskas, M; Jakubauskiene, L; Leber, B; Horvath, A; Strupas, K; Stiegler, P; Schemmer, P
Probiotic Supplementation Suppresses Tumor Growth in an Experimental Colorectal Cancer Liver Metastasis Model.
INT J MOL SCI. 2022; 23(14): 7674
Doi: 10.3390/ijms23147674
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Janisch, M; Adelsmayr, G; Müller, H; Holzinger, A; Janek, E; Talakic, E; Fuchsjäger, M; Schöllnast, H
Non-contrast-enhanced CT texture analysis of primary and metastatic pancreatic ductal adenocarcinomas: value in assessment of histopathological grade and differences between primary and metastatic lesions.
Abdom Radiol (NY). 2022; 47(12):4151-4159
Doi: 10.1007/s00261-022-03646-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Lechner, M; Takahashi, Y; Turri-Zanoni, M; Liu, J; Counsell, N; Hermsen, M; Kaur, RP; Zhao, T; Ramanathan, M; Schartinger, VH; Emanuel, O; Helman, S; Varghese, J; Dudas, J; Riechelmann, H; Sprung, S; Haybaeck, J; Howard, D; Engel, NW; Stewart, S; Brooks, L; Pickles, JC; Jacques, TS; Fenton, TR; Williams, L; Vaz, FM; O'Flynn, P; Stimpson, P; Wang, S; Hannan, SA; Unadkat, S; Hughes, J; Dwivedi, R; Forde, CT; Randhawa, P; Gane, S; Joseph, J; Andrews, PJ; Royle, G; Franchi, A; Maragliano, R; Battocchio, S; Bewicke-Copley, H; Pipinikas, C; Webster, A; Thirlwell, C; Ho, D; Teschendorff, A; Zhu, T; Steele, CD; Pillay, N; Vanhaesebroeck, B; Mohyeldin, A; Fernandez-Miranda, J; Park, KW; Le, QT; West, RB; Saade, R; Manes, RP; Omay, SB; Vining, EM; Judson, BL; Yarbrough, WG; Sansovini, M; Silvia, N; Grassi, I; Bongiovanni, A; Capper, D; Schüller, U; Thavaraj, S; Sandison, A; Surda, P; Hopkins, C; Ferrari, M; Mattavelli, D; Rampinelli, V; Facchetti, F; Nicolai, P; Bossi, P; Henriquez, OA; Magliocca, K; Solares, CA; Wise, SK; Llorente, JL; Patel, ZM; Nayak, JV; Hwang, PH; Lacy, PD; Woods, R; O'Neill, JP; Jay, A; Carnell, D; Forster, MD; Ishii, M; London, NR; Bell, DM; Gallia, GL; Castelnuovo, P; Severi, S; Lund, VJ; Hanna, EY
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.
Eur J Cancer. 2022; 162:221-236
Doi: 10.1016/j.ejca.2021.09.046
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Maisel, F; Smolle, MA; Mollnar, S; Riedl, JM; Barth, DA; Seles, M; Terbuch, A; Rossmann, CH; Eisner, F; Mannweiler, S; Hutterer, G; Zigeuner, R; Pummer, K; Smolle-Jüttner, FM; Lindenmann, J; Stotz, M; Gerger, A; Jost, PJ; Bauernhofer, T; Pichler, M; Posch, F
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis.
Clin Genitourin Cancer. 2022; 20(4):344-353
Doi: 10.1016/j.clgc.2022.03.010
Web of Science
PubMed
FullText
FullText_MUG
Nooromid, M; De, Martino, R; Squizzato, F; Benedetto, F; De, Caridi, G; Chou, EL; Conrad, MF; Pantoja, J; Abularrage, C; Sorber, R; Garcia-Ortega, DY; Luna-Ortiz, K; Eichler, C; Zarkowsky, D; Chia, M; Kalluri, A; Cohnert, T; Szeberin, Z; Grotemeyer, D; Shalhub, S; Fagg, D; Jackson, MJ; Charlton-Ouw, K; Gombert, A; Jacobs, M; Boyd, A; Motaganahalli, R; Uceda, D; Woo, K; Eskandari, MK, , Vascular, Low, Frequency, Disease, Consortium
Surgical resection and graft replacement for primary inferior vena cava leiomyosarcoma: A multicenter experience.
J Vasc Surg Venous Lymphat Disord. 2022; 10(3):617-625
Doi: 10.1016/j.jvsv.2021.06.021
Web of Science
PubMed
FullText
FullText_MUG
Pratsinis, M; Fankhauser, C; Pratsinis, K; Beyer, J; Bührer, E; Cathomas, R; Fischer, N; Hermanns, T; Hirschi-Blickenstorfer, A; Kamradt, J; Alex, Kluth, L; Zihler, D; Mingrone, W; Müller, B; Nestler, T; Rothschild, SI; Seifert, B; Templeton, AJ; Terbuch, A; Ufen, MP; Woelky, R; Gillessen, S; Rothermundt, C
Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses.
Eur Urol Open Sci. 2022; 40: 16-18.
Doi: 10.1016/j.euros.2022.03.013
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Seehofer, D; Sucher, R; Denecke, T
[Resection and transplantation for hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
Radiologe. 2022; 62(3): 210-218.
Doi: 10.1007/s00117-021-00962-9
Web of Science
PubMed
FullText
FullText_MUG
Suppan, C; Graf, R; Jahn, S; Zhou, Q; Klocker, EV; Bartsch, R; Terbuch, A; Kashofer, K; Regitnig, P; Lindenmann, J; Posch, F; Gerritsmann, H; Jost, PJ; Heitzer, E; Dandachi, N; Balic, M
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients.
Br J Cancer. 2022; 126(3):456-463
Doi: 10.1038/s41416-021-01601-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Zuckerman, LM; Scolaro, JA; Gardner, MP; Kern, T; Lanz, P; Quinnan, SM; Watson, JT; Rolfing, JD
Technical considerations for the management of segmental osseous defects with an internal bone transport nail
EXPERT REV MED DEVIC. 2022;
Doi: 10.1080/17434440.2022.2054336
Web of Science
PubMed
FullText
FullText_MUG
2021
Aftimos, P; Oliveira, M; Irrthum, A; Fumagalli, D; Sotiriou, C; Gal-Yam, EN; Robson, ME; Ndozeng, J; Di, Leo, A; Ciruelos, EM; de, Azambuja, E; Viale, G; Scheepers, ED; Curigliano, G; Bliss, JM; Reis-Filho, JS; Colleoni, M; Balic, M; Cardoso, F; Albanell, J; Duhem, C; Marreaud, S; Romagnoli, D; Rojas, B; Gombos, A; Wildiers, H; Guerrero-Zotano, A; Hall, P; Bonetti, A; Larsson, KF; Degiorgis, M; Khodaverdi, S; Greil, R; Sverrisdóttir, Á; Paoli, M; Seyll, E; Loibl, S; Linderholm, B; Zoppoli, G; Davidson, NE; Johannsson, OT; Bedard, PL; Loi, S; Knox, S; Cameron, DA; Harbeck, N; Montoya, ML; Brandão, M; Vingiani, A; Caballero, C; Hilbers, FS; Yates, LR; Benelli, M; Venet, D; Piccart, MJ
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.
Cancer Discov. 2021; 11(11): 2796-2811.
Doi: 10.1158/2159-8290.CD-20-1647
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Andrianakis, A; Kiss, P; Pomberger, M; Wolf, A; Thurnher, D; Tomazic, PV
Sinonasal mucosal melanoma: treatment strategies and survival rates for a rare disease entity : A single center experience and review of literature.
Wien Klin Wochenschr. 2021; 133(21-22):1137-1147
Doi: 10.1007/s00508-021-01847-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Barth, DA; Sareban, N; Lindner, AK; Daller, LAJ; Matzhold, EM; Hutterer, G; Smolle, M; Mischinger, J; Riedl, JM; Seles, M; Mannweiler, S; Bauernhofer, T; Pummer, K; Pichler, R; Zigeuner, R; Schlenke, P; Pichler, M
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Urol Oncol. 2021; 39(10):736.e9-736.e16
Doi: 10.1016/j.urolonc.2021.06.005
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Berger, M; Thueringer, A; Franz, D; Dandachi, N; Talakić, E; Richtig, G; Richtig, E; Rohrer, PM; Koch, L; Wolf, IH; Koch, C; Rainer, BM; Koeller, M; Pichler, M; Gerritsmann, H; Kashofer, K; Aigelsreiter, A
Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing-A Prospective Feasibility Study.
Cancers (Basel). 2021; 13(12):
Doi: 10.3390/cancers13123101
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Beyer, J; Collette, L; Sauvé, N; Daugaard, G; Feldman, DR; Tandstad, T; Tryakin, A; Stahl, O; Gonzalez-Billalabeitia, E; De, Giorgi, U; Culine, S; de, Wit, R; Hansen, AR; Bebek, M; Terbuch, A; Albany, C; Hentrich, M; Gietema, JA; Negaard, H; Huddart, RA; Lorch, A; Cafferty, FH; Heng, DYC; Sweeney, CJ; Winquist, E; Chovanec, M; Fankhauser, C; Stark, D; Grimison, P; Necchi, A; Tran, B; Heidenreich, A; Shamash, J; Sternberg, CN; Vaughn, DJ; Duran, I; Bokemeyer, C; Patrikidou, A; Cathomas, R; Assele, S; Gillessen, S, , International, Germ, Cell, Cancer, Classification, Update, Consortium
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.
J Clin Oncol. 2021; 39(14):1553-1562
Doi: 10.1200/JCO.20.03292
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Brunner, TB; Haustermans, K; Huguet, F; Morganti, AG; Mukherjee, S; Belka, C; Krempien, R; Hawkins, MA; Valentini, V; Roeder, F
ESTRO ACROP guidelines for target volume definition in pancreatic cancer.
Radiother Oncol. 2021; 154: 60-69.
Doi: 10.1016/j.radonc.2020.07.052
Web of Science
PubMed
FullText
FullText_MUG
Dandachi, N; Posch, F; Graf, R; Suppan, C; Klocker, EV; Müller, HD; Lindenmann, J; Terbuch, A; Heitzer, E; Balic, M
Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR+ breast cancer patients undergoing CDK4/6 treatment.
Mol Oncol. 2021; 15(9):2390-2400
Doi: 10.1002/1878-0261.12870
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Eichler, M; Andreou, D; Golcher, H; Hentschel, L; Richter, S; Hohenberger, P; Kasper, B; Pink, D; Jakob, J; Ashmawy, H; Hettmer, S; Tuchscherer, A; Grube, M; Heidt, V; Jentsch, C; Pablik, J; Wardelmann, E; Kreitner, KF; Kneser, U; Tonus, C; Wimberger, P; Schoffer, O; Reichardt, P; Wartenberg, M; Eberlein-Gonska, M; Bornhäuser, M; Schmitt, J; Schuler, MK
Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa Study.
Oncol Res Treat. 2021; 44(6):301-312
Doi: 10.1159/000516262
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fan, K; Spassova, I; Gravemeyer, J; Ritter, C; Horny, K; Lange, A; Gambichler, T; Ødum, N; Schrama, D; Schadendorf, D; Ugurel, S; Becker, JC
Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53.
Oncogene. 2021; 40(5):980-996
Doi: 10.1038/s41388-020-01576-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gampenrieder, SP; Rinnerthaler, G; Tinchon, C; Petzer, A; Balic, M; Heibl, S; Schmitt, C; Zabernigg, AF; Egle, D; Sandholzer, M; Singer, CF; Roitner, F; Hager, C; Andel, J; Hubalek, M; Knauer, M; Greil, R
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry.
BREAST CANCER RES. 2021; 23(1): 112
Doi: 10.1186/s13058-021-01492-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Geiger-Gritsch, S; Olschewski, H; Kocher, F; Wurm, R; Absenger, G; Flicker, M; Hermann, A; Heininger, P; Fiegl, M; Zechmeister, M; Endel, F; Wild, C; Pall, G
Real-world experience with anti-PD-1/PD-L1 monotherapy in patients with non-small cell lung cancer : A retrospective Austrian multicenter study.
Wien Klin Wochenschr. 2021; 133(21-22):1122-1130
Doi: 10.1007/s00508-021-01940-w
Web of Science
PubMed
FullText
FullText_MUG
Gillessen, S; Sauvé, N; Collette, L; Daugaard, G; de, Wit, R; Albany, C; Tryakin, A; Fizazi, K; Stahl, O; Gietema, JA; De, Giorgi, U; Cafferty, FH; Hansen, AR; Tandstad, T; Huddart, RA; Necchi, A; Sweeney, CJ; Garcia-Del-Muro, X; Heng, DYC; Lorch, A; Chovanec, M; Winquist, E; Grimison, P; Feldman, DR; Terbuch, A; Hentrich, M; Bokemeyer, C; Negaard, H; Fankhauser, C; Shamash, J; Vaughn, DJ; Sternberg, CN; Heidenreich, A; Beyer, J, , International, Germ, Cell, Cancer, Classification, Update, Consortium
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.
J Clin Oncol. 2021; 39(14):1563-1574
Doi: 10.1200/JCO.20.03296
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Grbčić, P; Eichmann, TO; Kraljević, Pavelić, S; Sedić, M
The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein.
Int J Mol Sci. 2021; 22(19):
Doi: 10.3390/ijms221910767
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Grob, JJ; Gaudy-Marqueste, C; Guminski, A; Malvehy, J; Basset-Seguin, N; Bertrand, B; Fernandez-Penas, P; Kaufmann, R; Zalaudek, I; Fargnoli, MC; Tagliaferri, L; Fertil, B; Del, Marmol, V; Stratigos, A; Garbe, C; Peris, K
Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomas.
J Eur Acad Dermatol Venereol. 2021; 35(11):2149-2153
Doi: 10.1111/jdv.17467
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Huang, CG; Li, MZ; Wang, SH; Tang, XQ; Haybaeck, J; Yang, ZH
The Application of Fine Needle Aspiration Biopsy in the Diagnosis of Axillary Masses.
Acta Cytol. 2021; 1-7.
Doi: 10.1159/000513149
Web of Science
PubMed
FullText
FullText_MUG
Keil, M; Conrad, T; Becker, M; Keilholz, U; Yaspo, ML; Lehrach, H; Schütte, M; Haybaeck, J; Hoffmann, J
Modeling of Personalized Treatments in Colon Cancer Based on Preclinical Genomic and Drug Sensitivity Data.
Cancers (Basel). 2021; 13(23):
Doi: 10.3390/cancers13236018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kocher, F; Tymoszuk, P; Amann, A; Sprung, S; Salcher, S; Daum, S; Haybaeck, J; Rinnerthaler, G; Huemer, F; Kauffmann-Guerrero, D; Tufman, A; Seeber, A; Wolf, D; Pircher, A
Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibition.
Lung Cancer. 2021; 159: 84-95.
Doi: 10.1016/j.lungcan.2021.06.020
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kretschmer, N; Hufner, A; Durchschein, C; Popodi, K; Rinner, B; Lohberger, B; Bauer, R
Synthesis and Pharmacological In Vitro Investigations of Novel Shikonin Derivatives with a Special Focus on Cyclopropane Bearing Derivatives.
Int J Mol Sci. 2021; 22(5):
Doi: 10.3390/ijms22052774
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Laprovitera, N; Riefolo, M; Ambrosini, E; Klec, C; Pichler, M; Ferracin, M
Cancer of Unknown Primary: Challenges and Progress in Clinical Management.
Cancers (Basel). 2021; 13(3):
Doi: 10.3390/cancers13030451
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Laprovitera, N; Riefolo, M; Porcellini, E; Durante, G; Garajova, I; Vasuri, F; Aigelsreiter, A; Dandachi, N; Benvenuto, G; Agostinis, F; Sabbioni, S; Berindan, Neagoe, I; Romualdi, C; Ardizzoni, A; Trerè, D; Pichler, M; D'Errico, A; Ferracin, M
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary.
Mol Oncol. 2021; 15(10):2732-2751
Doi: 10.1002/1878-0261.13026
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Lechner, M; Schartinger, VH; Steele, CD; Nei, WL; Ooft, ML; Schreiber, LM; Pipinikas, CP; Chung, GT; Chan, YY; Wu, F; To, KF; Tsang, CM; Pearce, W; Morelli, D; Philpott, M; Masterson, L; Nibhani, R; Wells, G; Bell, CG; Koller, J; Delecluse, S; Yip, YL; Liu, J; Forde, CT; Forster, MD; Jay, A; Dudás, J; Krapp, A; Wan, S; Uprimny, C; Sprung, S; Haybaeck, J; Fenton, TR; Chester, K; Thirlwell, C; Royle, G; Marafioti, T; Gupta, R; Indrasari, SR; Herdini, C; Slim, MAM; Indrawati, I; Sutton, L; Fles, R; Tan, B; Yeong, J; Jain, A; Han, S; Wang, H; Loke, KSH; He, W; Xu, R; Jin, H; Cheng, Z; Howard, D; Hwang, PH; Le, QT; Tay, JK; West, RB; Tsao, SW; Meyer, T; Riechelmann, H; Oppermann, U; Delecluse, HJ; Willems, SM; Chua, MLK; Busson, P; Lo, KW; Wollmann, G; Pillay, N; Vanhaesebroeck, B; Lund, VJ
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy.
Nat Commun. 2021; 12(1): 117-117.
Doi: 10.1038/s41467-020-20308-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Margonis, GA; Amini, N; Buettner, S; Kim, Y; Wang, J; Andreatos, N; Wagner, D; Sasaki, K; Beer, A; Kamphues, C; Morioka, D; Løes, IM; Imai, K; He, J; Pawlik, TM; Kaczirek, K; Poultsides, G; Lønning, PE; Burkhart, R; Endo, I; Baba, H; Mischinger, HJ; Aucejo, FN; Kreis, ME; Wolfgang, CL; Weiss, MJ
The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis.
Ann Surg. 2021; 273(6):1165-1172
Doi: 10.1097/SLA.0000000000003504
Web of Science
PubMed
FullText
FullText_MUG
Mohamed, AA; Thomsen, A; Follo, M; Zamboglou, C; Bronsert, P; Mostafa, H; Amen, A; Mekawy, M; Grosu, AL; Brunner, TB
FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro.
Strahlenther Onkol. 2021; 197(1): 27-38.
Doi: 10.1007/s00066-020-01666-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Weitere 50 Treffer anzeigen